NIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)

National Institutes of Health

The NIH Phase IIB Strategic Breakthrough award bridges the funding gap between the end of a Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase II award and commercialization. The Phase IIB Strategic Breakthrough provides previously funded NIH SBIR or STTR projects additional support for later-stage research and development (R&D).

Grant866 days left
Type
Grant
Deadline

Eligibility

Small businesses. Only United States small business concerns (SBCs) that have previously received an NIH SBIR or STTR Phase II award are eligible to submit applications for this opportunity. Only one NIH Phase IIB Strategic Breakthrough award is allowed per project. This NOFO supports Renewal/Resubmission "Type 2" Applications from recipients with NIH Phase II SBIR/STTR awards that are submitted within the first six due dates following the expiration of their budget period. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Open funding calls · National Institutes of Health

Open calls
  1. NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
  2. NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
  3. BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
  4. Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
  5. SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)

News on this topic

  1. Common Tiger launches The Daymaker, a 12.8-pound folding outdoor chair, priced at $499
  2. Sixteen44 cut methane in a Swiss barn by 60–70% with a plasma oxidation demonstrator
  3. Google contracts 50 MW of superhot geothermal power from Quaise Energy
  4. Slush 2026 opens today in Helsinki
  5. Valladolid Space Carbon Hub plans €25M for first CO2-measuring satellites in 2027–2028
More
Follow us

Type at least two letters — results appear instantly

↑↓to choose↵to openescto close